Chronic Bronchiolitis or Resistant Asthma?

This study has been completed.

First Received on August 22, 2006. Last Updated on February 17, 2009 History of Changes

Sponsor:	Baqiyatallah Medical Sciences University
Information provided by:	Baqiyatallah Medical Sciences University
ClinicalTrials.gov Identifier:	NCT00368342

Purpose

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Condition	Intervention	Phase
Asthma	Drug: Erythromycin, Azithromycin , Clarithromycin	Phase IV

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Drug Information available for: Erythromycin Gluceptate Clarithromycin Azithromycin Erythromycin Erythromycin stearate Erythromycin ethylsuccinate Erythromycin estolate

U.S. FDA Resources

Further study details as provided by Baqiyatallah Medical Sciences University:

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Difficult asthma

Exclusion Criteria:

Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
A history of smoking
Significant occupational or environmental exposures
Evidence on emphysema on chest high resolution computed tomography (HRCT) scan

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00368342

Sponsors and Collaborators

Baqiyatallah Medical Sciences University

Investigators

Principal Investigator:

Mostafa Ghanei, Prof

Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00368342 History of Changes
Other Study ID Numbers:	S-340-14-6-1-PU-79
Study First Received:	August 22, 2006
Last Updated:	February 17, 2009
Health Authority:	Iran: Ethics Committee

Additional relevant MeSH terms:

Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Erythromycin stearate
Erythromycin
Erythromycin Estolate

Erythromycin Ethylsuccinate
Clarithromycin
Azithromycin
Gastrointestinal Agents
Therapeutic Uses
Pharmacologic Actions
Protein Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Anti-Bacterial Agents
Anti-Infective Agents

ClinicalTrials.gov processed this record on February 09, 2012